CalciMedica’s (CALC) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $16.00 price target on the stock. CalciMedica Price Performance NASDAQ:CALC opened at $2.00 on Thursday. CalciMedica has a fifty-two week low of $1.43 and a fifty-two week […]
HC Wainwright reissued their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $16.00 price target on the stock. CalciMedica Price Performance NASDAQ:CALC opened at $2.00 on Thursday. CalciMedica has a fifty-two week low of $1.43 and a fifty-two week […]
